Context |
Access |
Age influences how fast patients are referred to specialized care |
Incidence |
Strong association between increasing age and increasing incidence rates for cancer |
Research |
Participants in clinical trials often younger than actual disease population |
Screening |
Strict age cut-offs for inclusion in public screening programs |
Guidelines |
Clinical guidelines use age thresholds when recommending treatment |
Patient |
Physiology |
Age-related declines in CYP enzymes responsible for hepatic drug metabolism |
Tumor biology |
Proportion of ER and HER2 status in breast cancer varies between age groups |
Comorbidity |
Association between increasing age and increasing number of comorbidities |
Receptivity |
Physicians’ recommendations are more influential for older patients |
Intervention |
Quality |
Older patients tend to receive substandard treatment |
Prediction |
Risk prediction tools use age for estimations |
Treatment outcome |
High age is often a predictor of decreased survival |